Minimal Change Disease and Monoclonal B-Cell Lymphocytosis: Is There an Association? (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO0752; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "In light of steroid-resistant disease and the potential role of B-cell dysregulation, the patient was treated with rituximab alongside a prednisone taper...In that report, rituximab and chlorambucil resulted in remission of both the B cell clone and MCD, supporting a pathogenic relationship...Notably, MCD is not yet a part of the spectrum of MGRS. A more consistent association between MCD and monoclonal disorders is needed to consider this a MGRS entity."
Chronic Lymphocytic Leukemia • Glomerulonephritis • Hematological Malignancies • Hodgkin Lymphoma • Leukemia • Lymphoma • Nephrology • Renal Disease
|
|
Luke Conlon; Josephine Abraham; Sarah Gilligan; Laith Al-Rabadi; Siddhartha Kakani
|